ArticleCureus2025
Knowledge and Awareness of Human Papillomavirus Vaccination in an Urbanized Village in Delhi.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCervical cancer is one of the major health problems and is a leading cause of death among women worldwide. Awareness regarding the prevention strategies against cervical cancer plays a major role in reducing its burden. Hence, the current study was planned with the objective to assess the level of awareness and knowledge regarding the human papillomavirus (HPV) vaccine. MATERIALS AND
methodsA cross-sectional study was conducted to include 405 participants using simple random sampling from an urbanized village of Delhi from March 2023 to April 2023. Data was collected using a pre-designed, semi-structured questionnaire. Tests of association, such as the chi-square test and its modifications, were used to determine statistical significance. P < 0.05 was taken as statistically significant.
resultsMost of the participants (95.6%) were not aware of the HPV vaccine. Only 1.75% correctly knew who needs the HPV vaccine, and 0.2% correctly knew at what age the vaccine is to be given. Out of those who knew about the HPV vaccine, 83% of study participants were willing to take the vaccine. No statistically significant association was found with the sociodemographic variables. Conclusion: There was a considerable lack of awareness and knowledge regarding the HPV vaccine among the residents of the urbanized village. Thus, it presents an opportunity that should be utilized to reach out and develop community awareness to encourage acceptance of the HPV vaccine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.